Selected Publications
- evoke and evoke+: design of two large-scale, double-blind, placebo-controlled, phase 3 studies evaluating efficacy, safety, and tolerability of semaglutide in early-stage symptomatic Alzheimer’s disease. Jeffrey L. Cummings, Alireza Atri, Howard H. Feldman, Oskar Hansson, Mary Sano, Filip K. Knop, Peter Johannsen, Teresa León, Philip Scheltens. Alzheimer's Research and Therapy
- Prognostic value of plasma biomarkers for informing clinical trial design in mild-to-moderate Alzheimer’s disease. Yuqi Qiu, Diane M. Jacobs, Karen Messer, David P. Salmon, Cheryl L. Wellington, Sophie Stukas, Carolyn Revta, James B. Brewer, Gabriel C. Léger, Brianna Askew, Lia Donahue, Stephen Kaplita, Vladimir Coric, Irfan A. Qureshi, Howard H. Feldman, Mark Brody, Jeffrey Ross, Anna Burke, Sudha Seshadri, Cherian Verghese, Stephen Flitman, Peter McCallister, Richard Shubin, Alexander Beyzer, James J. Peters, Mary Sano, Maya Lichtenstein, Clifford Singer, David Weisman, Kiran Bath, Olga Tchikindas, Sharon Brangman, Christos Sidiropoulos, Andrea Bozoki, Jeffrey Keller, Bernard Baumel, Olga Brawman-Mintzer, Jacobo Mintzer, Michael Karathanos, Ralph Richter, Charles Bernick, Aaron Ritter, Jonathan Drake, Elaine Peskind, Del D. Miller, Douglas Scharre, Alan Lerner, Alireza Atri, Bryan Spann, Alan Siegal. Alzheimer's Research and Therapy
- Ethnicity predicts long-term depressive symptom patterns in older adults with type 2 diabetes. Yuxia Ouyang, David Manier, Ramit Ravona-Springer, Mery Mamistalov, Dar Gelblum, Anthony Heymann, Joseph Azuri, Laili Soleimani, Ruby Phillips, Mary Sano, Michal Schnaider Beeri, Elizabeth Guerrero-Berroa. International Psychogeriatrics